Molecular Biomarkers & Diagnosis

Department of Biomarkers and Diagnostics, Moscow State University, Russia

Publications

• Brief Report   
  Exploring Novel Molecular Biomarkers in Early Detection of Neurodegenerative Diseases
  Author(s): Olga Rova*
  
  Neurodegenerative diseases, such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and Amyotrophic Lateral Sclerosis (ALS), are characterized by progressive neuronal damage and functional decline, significantly affecting the quality of life of those impacted. Early diagnosis is crucial for better disease management and improving therapeutic outcomes, yet the clinical diagnosis of these conditions is often made at advanced stages when irreversible neuronal damage has already occurred. Currently, most neurodegenerative diseases are diagnosed through clinical evaluation, neuroimaging, and sometimes post-mortem examination, but these methods lack the sensitivity and specificity needed for early detection. As a result, there is an urgent need for the developme.. Read More»
  DOI: 10.37421/2155-9929.2024.15.660

  Abstract HTML PDF